A Retrospective Study of Cemiplimab Effectiveness in Elderly Patients with Squamous Cell Carcinoma of the Skin: Insights from a Real-Life Scenario-Reference-Cited by-同舟云学术

A Retrospective Study of Cemiplimab Effectiveness in Elderly Patients with Squamous Cell Carcinoma of the Skin: Insights from a Real-Life Scenario

Published:2023-12-19 Issue: Volume: Page:
ISSN:2366-1070
Container-title:Oncology and Therapy
language:en
Short-container-title:Oncol Ther

Author:

Di Lorenzo Giuseppe,Michele Aieta,Silvana Leo,Bilancia Domenico,Di Trolio Rossella,Iuliucci Michela Rosaria,Ingenito Concetta,Rubino Roberta,Piscosquito Arianna,Caraglia Michele,Donnarumma Marianna,Costabile Ferdinando,Conca Raffaele,Pisino Marco,Vaia Angelo,Scafuri Luca,Verde Antonio,Buonerba Carlo

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

https://link.springer.com/content/pdf/10.1007/s40487-023-00256-1.pdf

Reference13 articles.

1. Rogers HW, Weinstock MA, Feldman SR, Coldiron BM. Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the US population, 2012. JAMA Dermatol. 2015;151:1081. https://doi.org/10.1001/jamadermatol.2015.1187.

2. Wysong A. Squamous-cell carcinoma of the skin. N Engl J Med. 2023;388:2262–73. https://doi.org/10.1056/NEJMra2206348.

3. Hillen U, Leiter U, Haase S, et al. Advanced cutaneous squamous cell carcinoma: a retrospective analysis of patient profiles and treatment patterns—results of a non-interventional study of the DeCOG. Eur J Cancer. 2018;96:34–43. https://doi.org/10.1016/j.ejca.2018.01.075.

4. Goodman DT. Cemiplimab and cutaneous squamous cell carcinoma: from bench to bedside. JPRAS Open. 2022;33:155–60. https://doi.org/10.1016/j.jpra.2022.06.003.

5. Migden MR, Rischin D, Schmults CD, et al. PD-1 blockade with cemiplimab in advanced cutaneous squamous-cell carcinoma. N Engl J Med. 2018;379:341–51. https://doi.org/10.1056/NEJMoa1805131.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cemiplimab;Reactions Weekly;2024-05-18